Soluble endothelial cell adhesion molecules and their relationship to disease activity in Takayasu's arteritis

Journal of Rheumatology

Volumn 35, Issue 9, 2008, Pages 1842-1845

  Tripathy, Naresh K ^a   Chandran, Vinod ^a   Garg, Naveen K ^a   Sinha, Nakul ^a   Nityanand, Soniya ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Disease activity; Soluble endothelial cell adhesion molecules; Takayasu's arteritis

Indexed keywords

AZATHIOPRINE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; AORTA ARCH SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; SCHOOL CHILD; VASCULAR DISEASE;

ADOLESCENT; ADULT; AZATHIOPRINE; CHILD; E-SELECTIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TAKAYASU ARTERITIS; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 54049150875     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Inder SJ, Bobryshev YV, Cherian SM, et al. Accumulation of lymphocytes, dendritic cells and granulocytes in the aortic wall affected by Takayasu's disease. Angiology 2000;51:565-79.
2. Kevil CG, Bullard DC. Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis. Am J Med 1999;106:677-87.
3. Pigott R, Dillon LP, Hemingway LH, et al. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584-9.
4. Nakai K, Itoh C, Kawazoe K, et al. Concentration of soluble vascular cell adhesion molecule -1(VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta. Coron Artery Dis 1995;6:497-502.
5. Arend WP, Michel BA, Bloch DA, et al. American College of Rheumatology criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
6. Tripathy NK, Sinha N, Nityanand S. Anti-annexin-V antibodies in Takayasu's arteritis and their relationship with disease activity. Clin Exp Immunol 2003;134:360-4.
7. Noguchi S, Numano F, Gravanis MB, Wilcox JN. Increased levels of soluble forms of adhesion molecules in Takayasu arteritis. Int J Cardiol 1998;66 Suppl 1:S23-33.
8. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998;66 Suppl 1:S191-4.
9. Tripathy NK, Chauhan SK, Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis. Clin Exp Immunol 2004;138:369-74.
10. Wais T, Fierz W, Stoll T, et al. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission. J Rheumatol 2003;30:2133-9.
11. Talwar KK, Vasan RS, Sharma S, et al. Non-specific aorto arteritis: long term follow-up on immunosuppressive therapy. Int J Cardiol 1993;39:79-84.
12. Hoffman GS. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol 1996;54 Suppl:83-6.
13. Stegeman CA, Tervaert JW, Huitema MG, et al. Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during follow up. Arthritis Rheum 1994;37:1228-35.
14. Coll-Vinent B, Grau JM, Lopez-Soto A, et al. Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. Br J Rheumatol 1997;36:1178-83.